Sonoma Pharmaceuticals, Inc. (SNOA): Price and Financial Metrics


Sonoma Pharmaceuticals, Inc. (SNOA): $0.97

-0.07 (-6.73%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SNOA Stock Summary

  • SONOMA PHARMACEUTICALS INC's market capitalization of $4,881,709 is ahead of just 1.52% of US-listed equities.
  • For SNOA, its debt to operating expenses ratio is greater than that reported by only 10.18% of US equities we're observing.
  • With a year-over-year growth in debt of -59.84%, SONOMA PHARMACEUTICALS INC's debt growth rate surpasses only 4.01% of about US stocks.
  • If you're looking for stocks that are quantitatively similar to SONOMA PHARMACEUTICALS INC, a group of peers worth examining would be IIIN, REX, FN, MPX, and SMID.
  • Visit SNOA's SEC page to see the company's official filings. To visit the company's web site, go to www.sonomapharma.com.

SNOA Valuation Summary

  • In comparison to the median Healthcare stock, SNOA's price/earnings ratio is 103.1% lower, now standing at -0.7.
  • Over the past 196 months, SNOA's price/earnings ratio has gone up 3.4.

Below are key valuation metrics over time for SNOA.

Stock Date P/S P/B P/E EV/EBIT
SNOA 2023-03-17 0.4 0.9 -0.7 -0.4
SNOA 2023-03-16 0.4 0.9 -0.7 -0.4
SNOA 2023-03-15 0.4 0.8 -0.7 -0.4
SNOA 2023-03-14 0.4 0.8 -0.7 -0.3
SNOA 2023-03-13 0.4 0.8 -0.6 -0.3
SNOA 2023-03-10 0.4 0.8 -0.7 -0.3

SNOA Growth Metrics

    Its 2 year net income to common stockholders growth rate is now at -72.64%.
  • Its 3 year net income to common stockholders growth rate is now at 56.89%.
  • Its year over year cash and equivalents growth rate is now at 75.26%.
SNOA's revenue has moved down $5,250,000 over the prior 52 months.

The table below shows SNOA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 12.556 -5.106 -6.787
2022-09-30 12.514 -5.084 -5.792
2022-06-30 12.927 -4.558 -4.875
2022-03-31 12.628 -4.248 -5.086
2021-12-31 12.487 -4.329 -5.802
2021-09-30 14.521 -3.257 -5.508

SNOA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SNOA has a Quality Grade of D, ranking ahead of 19.4% of graded US stocks.
  • SNOA's asset turnover comes in at 1.011 -- ranking 24th of 682 Pharmaceutical Products stocks.
  • AGLE, REGN, and NAVB are the stocks whose asset turnover ratios are most correlated with SNOA.

The table below shows SNOA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.011 0.348 -0.457
2021-03-31 1.064 0.352 -0.307
2020-12-31 1.210 0.393 -0.153
2020-09-30 1.226 0.405 -0.202
2020-06-30 1.214 0.411 -0.353
2020-06-30 1.305 0.416 -0.272

SNOA Stock Price Chart Interactive Chart >

Price chart for SNOA

SNOA Price/Volume Stats

Current price $0.97 52-week high $4.25
Prev. close $1.04 52-week low $0.90
Day low $0.97 Volume 501
Day high $0.97 Avg. volume 2,085,711
50-day MA $1.33 Dividend yield N/A
200-day MA $2.12 Market Cap 4.51M

Sonoma Pharmaceuticals, Inc. (SNOA) Company Bio


Sonoma Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. Sonoma Pharmaceuticals serves customers worldwide.


SNOA Latest News Stream


Event/Time News Detail
Loading, please wait...

SNOA Latest Social Stream


Loading social stream, please wait...

View Full SNOA Social Stream

Latest SNOA News From Around the Web

Below are the latest news stories about SONOMA PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SNOA as an investment opportunity.

Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims and Green Seal Certification for Nanocyn(R) Hospital-Grade Disinfectant

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions and disinfectant use, and its partner, the MicroSafe Group DMCC, are excited to announce that Nanocyn® hospital-grade disinfectant has received additional claims from the

Yahoo | March 2, 2023

Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA),a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions, today announced financial results for its third fiscal quarter and nine months ended December 31, 2022.

Yahoo | February 14, 2023

Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical for Distribution of Primocyn Skin Care in South Korea

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including dermatology, eye, oral and nasal care, and wound care, today announced that it has entered into a distribution agreement with Daewoong Pharmaceutical Co., Ltd. for the marketing and distribution of PrimocynTM Skin Solution products

Yahoo | January 31, 2023

NEE Stock Alert: NextEra Energy Announces Leadership Changes

NextEra Energy (NEE) stock is on the move Wednesday after the Florida energy company announced changes to its leadership.

William White on InvestorPlace | January 25, 2023

NWSA Stock Alert: What to Know as Rupert Murdoch Abandons Merger Plans

News Corporation (NWSA) stock is in the news Wednesday after a merger plan between it and Fox Corporation (FOXA,FOX) was terminated.

William White on InvestorPlace | January 25, 2023

Read More 'SNOA' Stories Here

SNOA Price Returns

1-mo -32.64%
3-mo -15.65%
6-mo -55.50%
1-year -70.69%
3-year -82.98%
5-year -97.13%
YTD -13.39%
2022 -75.44%
2021 -37.19%
2020 66.51%
2019 -31.77%
2018 -86.97%

Continue Researching SNOA

Want to see what other sources are saying about Sonoma Pharmaceuticals Inc's financials and stock price? Try the links below:

Sonoma Pharmaceuticals Inc (SNOA) Stock Price | Nasdaq
Sonoma Pharmaceuticals Inc (SNOA) Stock Quote, History and News - Yahoo Finance
Sonoma Pharmaceuticals Inc (SNOA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9325 seconds.